Listed

Spero Therapeutics, Inc.

SPRONasdaqCIK 1701108HealthcareFiscal year ends Dec 31

Reports and events: 174 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Spero Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0108:10 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-267758
2023-10-1616:01 ET8-K/A5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-256865
2023-10-1008:28 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-253136
2023-09-0116:08 ETDEF 14AProxy statementPeriod 2023-10-050001193125-23-227642
2023-08-1016:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-209064
2023-08-1016:09 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-041314
2023-07-3108:12 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-198589
2023-06-1408:12 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-166543
2023-05-1116:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-142023
2023-05-1116:02 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021187
2023-03-3016:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-085566
2023-03-3016:02 ET10-KAnnual reportPeriod 2022-12-310000950170-23-010921
2023-02-0116:29 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-021612
2023-01-0908:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-004190
2022-11-1416:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-284579
2022-11-1416:04 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-024971
2022-11-0808:12 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-279724
2022-09-2208:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-248772
2022-09-1917:14 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-22-247168
2022-09-0608:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-238439
2022-08-1016:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-217351
2022-08-1016:03 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016443
2022-08-0516:06 ETDEF 14AProxy statementPeriod 2022-09-150001193125-22-213583
2022-07-0116:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-187190
2022-06-2716:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-182828
2022-06-0716:01 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001193125-22-169252
2022-05-1616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-151708
2022-05-1616:03 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-010064
2022-05-0307:15 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-137586
2022-04-0717:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-097712
2022-03-3116:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-091793
2022-03-3116:02 ET10-KAnnual reportPeriod 2021-12-310000950170-22-005194
2022-02-1608:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-044007
2022-01-2508:27 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-016568
2022-01-1908:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-011967
2022-01-0408:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-001112
2021-11-1016:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-326025
2021-11-1016:02 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-004064
2021-10-2808:13 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-310428
2021-10-1208:13 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-296407
2021-09-3008:14 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-21-287391
2021-08-3016:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-260572
2021-08-1816:48 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-250505
2021-08-0516:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-237754
2021-08-0516:02 ET10-QQuarterly reportPeriod 2021-06-300000950170-21-000924
2021-07-0612:39 ETDEF 14AProxy statementPeriod 2021-08-170001193125-21-208448
2021-07-0119:23 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-21-205054
2021-05-0616:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-153274
2021-05-0616:02 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-024932
2021-03-2316:02 ET10-K/AAnnual report, amendedPeriod 2020-12-310001193125-21-091148

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.